Pediatric melanoma of the head and neck: A single institutions experience

Laryngoscope

Volumn 116, Issue 12, 2006, Pages 2216-2220

  French, James C ^a   Rowe, Mark R ^a,b   Lee, T J O ^a   Zwart, Jonathan E ^a  

^a LOMA LINDA UNIVERSITY CHILDREN S HOSPITAL   (United States)

^b LOMA LINDA UNIVERSITY   (United States)

Author keywords

Interferon; Pediatric melanoma; PET scan; Sentinel lymph node biopsy

Indexed keywords

ALPHA2B INTERFERON;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EXPERIENTIAL LEARNING; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; INFANT; MALE; MELANOMA; NECK DISSECTION; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIODIAGNOSIS; SENTINEL LYMPH NODE BIOPSY; TREATMENT INDICATION;

ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INTERFERON ALFA-2B; MALE; MELANOMA; NEOPLASM INVASIVENESS; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY;

EID: 33845482078     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000244371.93393.1e     Document Type: Article

References (21)

1. Varan A, Gokoz A, Akyuz C, et al. Primary malignant skin tumors in children: etiology, treatment and prognosis. Pediatr Int 2005;47:653-657.
2. Ferrari A, Bono A, Baldi M, et al. Does melanoma behave differently in younger children than in adults? A retrospective study of 33 cases of childhood melanoma from a single institution. Pediatrics 2005;115:649-654.
3. Sharfman W, Lange J, Balch CM. Pediatric melanoma. Pediatric Blood Cancer 2005;44:431-432.
4. Strouse JJ, Fears TR, Tucker MA, Wayne AS. Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database. J Clin Oncol 2005;23:4735-4741.
5. Chao MM, Schwartz JL, Wechsler DS, Thornburg CD, Griffith KA, Williams JA. High-risk surgically resected pediatric melanoma and adjuvant interferon therapy. Pediatric Blood Cancer 2005;44:441-448.
6. Pappo AS. Melanoma in children and adolescents. Eur J Cancer 2003;39:2651-2661.
7. O-Lee TJ, Rowe M. Auricular malignant melanoma of early childhood: the role of sentinel node biopsy. Int J Pediatr Otorhinolaryngol 2004;68:1345-1348.
8. Chao C, Wong SL, Edwards MJ, et al. Sentinel lymph node biopsy for head and neck melanomas. Ann Surg Oncol 2003;10:21-26.
9. Bleicher RJ, Essner R, Fashag LJ, Wornek LA, Morton DL. Role of sentinel lymphadenectomy in thin invasive cutaneous melanomas. J Clin Oncol 2003;21:1326-1331.
10. Bütter A, Hui T, Chapdelaine J, Beaunoyer M, Flageole H, Bouchard S. Melanoma in children and the use of sentinel lymph node biopsy. J Pediatr Surg 2005;40:797-800.
11. Zuckerman R, Maier JP, Guiney WB Jr, Huntsman WT, Mooney EK. Pediatric melanoma: confirming the diagnosis with sentinel node biopsy. Ann Plast Surg 2001;46:394-398.
12. Roaten JB, Partrick DA, Bensard D, et al. Survival in sentinel lymph node-positive pediatric melanoma. J Pediatr Surg 2005;40:988-992.
13. Kirkwood JM, Strawderman MH, Ernstoff MS, Smith TJ, Borden EC, Blum RH. Interferon alpha-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol 1996;14:7-17.
14. Navid F, Furman WL, Fleming M, et al. The feasibility of adjuvant interferon α-2b in children with high-risk melanoma. Cancer 2005;103:780-787.
15. Gibbs P, Moore A, Robinson W, Walsh P, Golitz L, Gonzalez R. Pediatric melanoma: are recent advances in the management of adult melanoma relevant to the pediatric population. J Pediatr Hematol Oncol 2000;22:428-432.
16. Pacella SJ, Lowe L, Bradford C, Marcus BC, Johson T, Rees R. The utility of sentinel lymph node biopsy in head and neck melanoma in the pediatric population. Plast Reconstr Surg 2003;112:1257-1265.
17. Roaten JB, Patrick DA, Pearlman N, Gonzalez RJ, Gonzalez R, McCarter MD. Sentinel lymph node biopsy for melanoma and other melanocytic tumors in adolescents. J Pediatr Surg 2005;40:232-235.
18. Mack LA, McKinnon JG. Controversies in the management of metastatic melanoma to regional lymphatic basins. J Surg Oncol 2004;86:189-199.
19. Brady MS, Akhurst T, Spanknebelk, et al. Utility of preoperative [(18)]F fluorodeoxyglucose-positron emission tomography scanning in high-risk melanoma patients. Ann Surg Oncol 2006;13:525-532.
20. Freidman KP, Wahl RL. Clinical use of positron emission tomography in the management of cutaneous melanoma. Semin Nucl Med 2004;34:242-253.
21. Kumar R, Mavi A, Bural G, Alavi A. Fluorodeoxyglucose-PET in the management of malignant melanoma. Radiol Clin North Am 2005;43:23-33.